Ischemic brain injury in cerebral amyloid angiopathy

Journal of Cerebral Blood Flow and Metabolism

Volumn 36, Issue 1, 2016, Pages 40-54

  Reijmer, Yael D ^a   Van Veluw, Susanne J ^a,b   Greenberg, Steven M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Amyloid angiopathy; brain imaging; dementia; focal ischemia; vascular cognitive impairment

Indexed keywords

CORTICOSTEROID; DONEPEZIL; GALANTAMINE;

AUTOPSY; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COGNITION; COGNITIVE DEFECT; CORTICOSTEROID THERAPY; DIFFUSION TENSOR IMAGING; HISTOPATHOLOGY; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VASCULAR AMYLOIDOSIS; WHITE MATTER; WHITE MATTER LESION; CEREBRAL AMYLOID ANGIOPATHY; COGNITION DISORDERS; COMPLICATION; DRUG EFFECTS; MICROVASCULATURE; PATHOLOGY; VASCULARIZATION;

BRAIN ISCHEMIA; CEREBRAL AMYLOID ANGIOPATHY; COGNITION DISORDERS; DIFFUSION TENSOR IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MICROVESSELS; WHITE MATTER;

EID: 84951570038     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2015.88     Document Type: Review

References (160)

1. Finelli PF, Kessimian N and Bernstein PW. Cerebral amyloid angiopathy manifesting as recurrent intracerebral hemorrhage. Arch Neurol 1984; 41: 330-333
2. Greenberg SM, Gurol ME, Rosand J and Smith EE. Amyloid angiopathy-related vascular cognitive impairment. Stroke 2004; 35: 2616-2619
3. Jellinger KA. Vascular-ischemic dementia: an update. J Neural Transm Suppl 2002; 62: 1-23
4. Neuropathology Group. Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 2001; 357: 169-175
5. Gurol ME, Viswanathan A, Gidicsin C, Hedden T, Martinez-Ramirez S, Dumas A, et al. Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study. Ann Neurol 2013; 73: 529-536
6. Haglund M, Passant U, Sjobeck M, Ghebremedhin E and Englund E. Cerebral amyloid angiopathy and cortical microinfarcts as putative substrates of vascular dementia. Int J Geriatr Psychiatry 2006; 21: 681-687
7. Holland CM, Smith EE, Csapo I, Gurol ME, Brylka DA, Killiany RJ, et al. Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke 2008; 39: 1127-1133
8. Kovari E, Herrmann FR, Hof PR and Bouras C. The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease. Neuropathol Appl Neurobiol 2013; 39: 498-509
9. De Reuck J, Deramecourt V, Cordonnier C, Leys D, Maurage CA and Pasquier F. The impact of cerebral amyloid angiopathy on the occurrence of cerebrovascular lesions in demented patients with Alzheimer features: a neuropathological study. Eur J Neurol 2011; 18: 913-918
10. Smith EE, Schneider JA, Wardlaw JM and Greenberg SM. Cerebral microinfarcts: the invisible lesions. Lancet Neurol 2012; 11: 272-282
11. Pfeifer LA, White LR, Ross GW, Petrovitch H and Launer LJ. Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology 2002; 58: 1629-1634
12. Arvanitakis Z, Leurgans SE, Wang Z, Wilson RS, Bennett DA and Schneider JA. Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol 2011; 69: 320-327
13. Ellis RJ, Olichney JM, Thal LJ, Mirra SS, Morris JC, Beekly D, et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology 1996; 46: 1592-1596
14. Zhang-Nunes SX, Maat-Schieman ML, van Duinen SG, Roos RA, Frosch MP and Greenberg SM. The cerebral beta-amyloid angiopathies: hereditary and sporadic. Brain Pathol 2006; 16: 30-39
15. Thal DR, Capetillo-Zarate E, Larionov S, Staufenbiel M, Zurbruegg S and Beckmann N. Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances. Neurobiol Aging 2009; 30: 1936-1948
16. Vonsattel JP, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED and Richardson EP Jr. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 1991; 30: 637-649
17. Wisniewski HM and Wegiel J. Beta-amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol 1994; 87: 233-241
18. Davis-Salinas J, Saporito-Irwin SM, Cotman CW, Van and Nostrand WE. Amyloid beta-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J Neurochem 1995; 65: 931-934
19. Herzig MC, Winkler DT, Burgermeister P, Pfeifer M, Kohler E, Schmidt SD, et al. Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci 2004; 7: 954-960
20. Davis J, Xu F, Deane R, Romanov G, Previti ML, Zeigler K, et al. Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/ Iowa mutant form of amyloid beta-protein precursor. J Biol Chem 2004; 279: 20296-20306
21. Vidal R, Barbeito AG, Miravalle L and Ghetti B. Cerebral amyloid angiopathy and parenchymal amyloid deposition in transgenic mice expressing the Danish mutant form of human BRI2. Brain Pathol 2009; 19: 58-68
22. Herzig MC, Van Nostrand WE and Jucker M. Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol 2006; 16: 40-54
23. Weller RO, Subash M, Preston SD, Mazanti I and Carare RO. Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol 2008; 18: 253-266
24. Hawkes CA, Hartig W, Kacza J, Schliebs R, Weller RO, Nicoll JA, et al. Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy. Acta Neuropathol 2011; 121: 431-443
25. Deane R, Wu Z, Sagare A, Davis J, Du Yan S, Hamm K, et al. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 2004; 43: 333-344
26. Mandybur TI. Cerebral amyloid angiopathy: the vascular pathology and complications. J Neuropathol Exp Neurol 1986; 45: 79-90
27. Zekry D, Duyckaerts C, Belmin J, Geoffre C, Herrmann F, Moulias R, et al. The vascular lesions in vascular and mixed dementia: the weight of functional neuroanatomy. Neurobiol Aging 2003; 24: 213-219
28. Vinters HV, Natte R, Maat-Schieman ML, van Duinen SG, Hegeman-Kleinn I, Welling-Graafland C, et al. Secondary microvascular degeneration in amyloid angiopathy of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D). Acta Neuropathol 1998; 95: 235-244
29. Love S, Chalmers K, Ince P, Esiri M, Attems J, Jellinger K, et al. Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. Am J Neurodegener Dis 2014; 3: 19-32
30. Vinters HV and Gilbert JJ. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 1983; 14: 924-928
31. Thal DR, Ghebremedhin E, Orantes Mand Wiestler OD. Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline. J Neuropathol Exp Neurol 2003; 62: 1287-1301
32. van Rooden S, van der Grond J, van den Boom R, Haan J, Linn J, Greenberg SM, et al. Descriptive analysis of the Boston criteria applied to a Dutch-type cerebral amyloid angiopathy population. Stroke 2009; 40: 3022-3027
33. Knudsen KA, Rosand J, Karluk D and Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 2001; 56: 537-539
34. Greenberg SM, Nandigam RN, Delgado P, Betensky RA, Rosand J, Viswanathan A, et al. Microbleeds versus macrobleeds: evidence for distinct entities. Stroke 2009; 40: 2382-2386
35. Shoamanesh A, Kwok CS and Benavente O. Cerebral microbleeds: histopathological correlation of neuroimaging. Cerebrovasc Dis 2011; 32: 528-534
36. Schrag M, McAuley G, Pomakian J, Jiffry A, Tung S, Mueller C, et al. Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathol 2010; 119: 291-302
37. Greenberg SM, Al-Shahi Salman R, Biessels GJ, van Buchem M, Cordonnier C, Lee JM, et al. Outcome markers for clinical trials in cerebral amyloid angiopathy. Lancet Neurol 2014; 13: 419-428
38. Cordonnier C and van der Flier WM. Brain microbleeds and Alzheimer's disease: innocent observation or key player? Brain 2011; 134: 335-344
39. Charidimou A, Gang Q and Werring DJ. Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry 2012; 83: 124-137
40. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013; 12: 822-838
41. Chen YW, Gurol ME, Rosand J, Viswanathan A, Rakich SM, Groover TR, et al. Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology 2006; 67: 83-87
42. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010; 9: 689-701
43. Wardlaw JM. Blood-brain barrier and cerebral small vessel disease. J Neurol Sci 2010; 299: 66-71
44. Gouw AA, Seewann A, van der Flier WM, Barkhof F, Rozemuller AM, Scheltens P, et al. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 2011; 82: 126-135
45. Haglund M and Englund E. Cerebral amyloid angiopathy, white matter lesions and Alzheimer encephalopathy-a histopathological assessment. Dement Geriatr Cogn Disord 2002; 14: 161-166
46. van Horssen J, de Jong D, de Waal RM, Maass C, Otte-Holler I, Kremer B, et al. Cerebral amyloid angiopathy with severe secondary vascular pathology: a histopathological study. Dement Geriatr Cogn Disord 2005; 20: 321-330
47. Conklin J, Silver FL, Mikulis DJ and Mandell DM. Are acute infarcts the cause of leukoaraiosis? Brain mapping for 16 consecutive weeks. Ann Neurol 2014; 76: 899-904
48. Bornebroek M, Haan J, van Buchem MA, Lanser JB, de Vries-vd Weerd MA, Zoeteweij M, et al. White matter lesions and cognitive deterioration in presymptomatic carriers of the amyloid precursor protein gene codon 693 mutation. Arch Neurol 1996; 53: 43-48
49. Ly JV, Donnan GA, Villemagne VL, Zavala JA, Ma H, O'Keefe G, et al. 11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage. Neurology 2010; 74: 487-493
50. Johnson KA, Gregas M, Becker JA, Kinnecom C, Salat DH, Moran EK, et al. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol 2007; 62: 229-234
51. Gurol ME, Dierksen G, Betensky R, Gidicsin C, Halpin A, Becker A, et al. Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy. Neurology 2012; 79: 320-326
52. Thanprasertsuk S, Martinez-Ramirez S, Pontes-Neto OM, Ni J, Ayres A, Reed A, et al. Posterior white matter disease distribution as a predictor of amyloid angiopathy. Neurology 2014; 83: 1-7
53. Zhu YC, Chabriat H, Godin O, Dufouil C, Rosand J, Greenberg SM, et al. Distribution of white matter hyperintensity in cerebral hemorrhage and healthy aging. J Neurol 2012; 259: 530-536
54. Brundel M, de Bresser J, van Dillen JJ, Kappelle LJ and Biessels GJ. Cerebral microinfarcts: a systematic review of neuropathological studies. J Cereb Blood Flow Metab 2012; 32: 425-436
55. Olichney JM, Hansen LA, Hofstetter CR, Grundman M, Katzman R and Thal LJ. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol 1995; 52: 702-708
56. Soontornniyomkij V, Lynch MD, Mermash S, Pomakian J, Badkoobehi H, Clare R, et al. Cerebral microinfarcts associated with severe cerebral beta-amyloid angiopathy. Brain Pathol 2010; 20: 459-467
57. Okamoto Y, Yamamoto T, Kalaria RN, Senzaki H, Maki T, Hase Y, et al. Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts. Acta Neuropathol 2012; 123: 381-394
58. Launer LJ, Petrovitch H, Ross GW, Markesbery W and White LR. AD brain pathology: vascular origins? Results from the HAAS autopsy study. Neurobiol Aging 2008; 29: 1587-1590
59. Gregoire SM, Charidimou A, Gadapa N, Dolan E, Antoun N, Peeters A, et al. Acute ischaemic brain lesions in intracerebral haemorrhage: multicentre cross-sectional magnetic resonance imaging study. Brain 2011; 134: 2376-2386
60. Kimberly WT, Gilson A, Rost NS, Rosand J, Viswanathan A, Smith EE, et al. Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology 2009; 72: 1230-1235
61. Auriel E, Gurol ME, Ayres A, Dumas AP, Schwab KM, Vashkevich A, et al. Characteristic distributions of intracerebral hemorrhage-associated diffusion-weighted lesions. Neurology 2012; 79: 2335-2341
62. Auriel E, Edlow BL, Reijmer YD, Fotiadis P, Ramirez-Martinez S, Ni J, et al. Microinfarct disruption of white matter structure: A longitudinal diffusion tensor analysis. Neurology 2014; 83: 182-188
63. Westover MB, Bianchi MT, Yang C, Schneider JA and Greenberg SM. Estimating cerebral microinfarct burden from autopsy samples. Neurology 2013; 80: 1365-1369
64. Sonnen JA, Larson EB, Crane PK, Haneuse S, Li G, Schellenberg GD, et al. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 2007; 62: 406-413
65. Launer LJ, Hughes TM and White LR. Microinfarcts brain atrophy, and cognitive function: the Honolulu Asia Aging Study Autopsy Study. Ann Neurol 2011; 70: 774-780
66. Sinka L, Kovari E, Gold G, Hof PR, Herrmann FR, Bouras C, et al. Small vascular and Alzheimer diseaserelated pathologic determinants of dementia in the oldestold. J Neuropathol Exp Neurol 2010; 69: 1247-1255
67. van Veluw SJ, Zwanenburg JJ, Engelen-Lee J, Spliet WG, Hendrikse J, Luijten PR, et al. In vivo detection of cerebral cortical microinfarcts with high-resolution 7T MRI. J Cereb Blood Flow Metab 2013; 33: 322-329
68. van Veluw SJ, Zwanenburg JJ, Rozemuller AJ, Luijten PR, Spliet WG and Biessels GJ. The spectrum of MR detectable cortical microinfarcts: a classification study with 7-tesla postmortem MRI and histopathology. J Cereb Blood Flow Metab 2015; 35: 676-683
69. van Rooden S, Doan NT, Versluis MJ, Goos JD, Webb AG, Oleksik AM, et al. 7T T2()-weighted magnetic resonance imaging reveals cortical phase differences between early-and late-onset Alzheimer's disease. Neurobiol Aging 2015; 36: 20-26
70. De Guio F, Reyes S, Vignaud A, Duering M, Ropele S, Duchesnay E, et al. In vivo high-resolution 7 Tesla MRI shows early and diffuse cortical alterations in CADASIL. PLoS One 2014; 9: e106311
71. Salat DH, Chen JJ, van der Kouwe AJ, Greve DN, Fischl B and Rosas HD. Hippocampal degeneration is associated with temporal and limbic gray matter/white matter tissue contrast in Alzheimer's disease. Neuroimage 2011; 54: 1795-1802
72. Jones DK and Leemans A. Diffusion tensor imaging. Methods Mol Biol 2011; 711: 127-144
73. Papma JM, de Groot M, de Koning I, Mattace-Raso FU, van der Lugt A, Vernooij MW, et al. Cerebral small vessel disease affects white matter microstructure in mild cognitive impairment. Hum Brain Mapp 2014; 35: 2836-2851
74. van Norden AGW, de Laat KF, van Dijk EJ, van Uden IWM, van Oudheusden LJB, Gons RAR, et al. Diffusion tensor imaging and cognition in cerebral small vessel disease. The RUN DMC study. Biochim Biophys Acta 2012; 1822: 401-407
75. O'Sullivan M, Summers PE, Jones DK, Jarosz JM, Williams SC and Markus HS. Normal-appearing white matter in ischemic leukoaraiosis: a diffusion tensor MRI study. Neurology 2001; 57: 2307-2310
76. Hsu JL, Chen YL, Leu JG, Jaw FS, Lee CH, Tsai YF, et al. Microstructural white matter abnormalities in type 2 diabetes mellitus: a diffusion tensor imaging study. Neuroimage 2012; 59: 1098-1105
77. de Groot M, Ikram MA, Akoudad S, Krestin GP, Hofman A, van der Lugt A, et al. Tract-specific white matter degeneration in aging. The Rotterdam Study. Alzheimers Dement 2014; 11: 321-330
78. Heringa SM, Reijmer YD, Leemans A, Koek HL, Kappelle LJ and Biessels GJ. Multiple Microbleeds are Related to Cerebral Network Disruptions in Patients with Early Alzheimer's Disease. J Alzheimers Dis 2014; 38: 211-221
79. Salat DH, Smith EE, Tuch DS, Benner T, Pappu V, Schwab KM, et al. White matter alterations in cerebral amyloid angiopathy measured by diffusion tensor imaging. Stroke 2006; 37: 1759-1764
80. Reijmer YD, Fotiadis P, Martinez-Ramirez S, Salat DH, Schultz A, Shoamanesh A, et al. Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy. Brain 2014; 138: 179-188
81. Akoudad S, de Groot M, Koudstaal PJ, van der Lugt A, Niessen WJ, Hofman A, et al. Cerebral microbleeds are related to loss of white matter structural integrity. Neurology 2013; 81: 1930-1937
82. Premkumar DR, Cohen DL, Hedera P, Friedland RP and Kalaria RN. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 1996; 148: 2083-2095
83. Milner E, Zhou ML, Johnson AW, Vellimana AK, Greenberg JK, Holtzman DM, et al. Cerebral amyloid angiopathy increases susceptibility to infarction after focal cerebral ischemia in Tg2576 mice. Stroke 2014; 45: 3064-3069
84. Hartz AM, Bauer B, Soldner EL, Wolf A, Boy S, Backhaus R, et al. Amyloid-beta contributes to bloodbrain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Stroke 2012; 43: 514-523
85. Shin HK, Jones PB, Garcia-Alloza M, Borrelli L, Greenberg SM, Bacskai BJ, et al. Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain 2007; 130: 2310-2319
86. Kimchi EY, Kajdasz S, Bacskai BJ and Hyman BT. Analysis of cerebral amyloid angiopathy in a transgenic mouse model of Alzheimer disease using in vivo multiphoton microscopy. J Neuropathol Exp Neurol 2001; 60: 274-279
87. Han BH, Zhou ML, Abousaleh F, Brendza RP, Dietrich HH, Koenigsknecht-Talboo J, et al. Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition. J Neurosci 2008; 28: 13542-13550
88. Smith EE, Vijayappa M, Lima F, Delgado P, Wendell L, Rosand J, et al. Impaired visual evoked flow velocity response in cerebral amyloid angiopathy. Neurology 2008; 71: 1424-1430
89. Dumas A, Dierksen GA, Gurol ME, Halpin A, Martinez-Ramirez S, Schwab K, et al. Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy. Ann Neurol 2012; 72: 76-81
90. Peca S, McCreary CR, Donaldson E, Kumarpillai G, Shobha N, Sanchez K, et al. Neurovascular decoupling is associated with severity of cerebral amyloid angiopathy. Neurology 2013; 81: 1659-1665
91. Garcia-Alloza M, Gregory J, Kuchibhotla KV, Fine S, Wei Y, Ayata C, et al. Cerebrovascular lesions induce transient beta-amyloid deposition. Brain 2011; 134: 3697-3707
92. Weller RO, Hawkes CA, Kalaria RN, Werring DJ and Carare RO. White matter changes in dementia: role of impaired drainage of interstitial fluid. Brain Pathol 2015; 25: 63-78
93. Charidimou A, Jaunmuktane Z, Baron JC, Burnell M, Varlet P, Peeters A, et al. White matter perivascular spaces: an MRI marker in pathology-proven cerebral amyloid angiopathy? Neurology 2014; 82: 57-62
94. Martinez-Ramirez S, Pontes-Neto OM, Dumas AP, Auriel E, Halpin A, Quimby M, et al. Topography of dilated perivascular spaces in subjects from a memory clinic cohort. Neurology 2013; 80: 1551-1556
95. Yakushiji Y, Charidimou A, Hara M, Noguchi T, Nishihara M, Eriguchi M, et al. Topography and associations of perivascular spaces in healthy adults: the Kashima scan study. Neurology 2014; 83: 2116-2123
96. Menon RS and Kidwell CS. Neuroimaging demonstration of evolving small vessel ischemic injury in cerebral amyloid angiopathy. Stroke 2009; 40: e675-e677
97. Rosidi NL, Zhou J, Pattanaik S, Wang P, Jin W, Brophy M, et al. Cortical microhemorrhages cause local inflammation but do not trigger widespread dendrite degeneration. PLoS ONE 2011; 6: e26612
98. Natte R, Maat-Schieman ML, Haan J, Bornebroek M, Roos RA and van Duinen SG. Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann Neurol 2001; 50: 765-772
99. Zarow C, Zaias B, Lyness SA and Chui H. Cerebral amyloid angiopathy in Alzheimer disease is associated with apolipoprotein E4 and cortical neuron loss. Alzheimer Dis Assoc Disord 1999; 13: 1-8
100. Nave KA. Myelination and support of axonal integrity by glia. Nature 2010; 468: 244-252
101. Brundel M, Heringa SM, de BJ, Koek HL, Zwanenburg JJ, Jaap KL, et al. High prevalence of cerebral microbleeds at 7Tesla MRI in patients with early Alzheimer's disease. J Alzheimers Dis 2012; 31: 259-263
102. Pettersen JA, Sathiyamoorthy G, Gao FQ, Szilagyi G, Nadkarni NK, St, George-Hyslop P, et al. Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study. Arch Neurol 2008; 65: 790-795
103. Staekenborg SS, Koedam EL, Henneman WJ, Stokman P, Barkhof F, Scheltens P, et al. Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy. Stroke 2009; 40: 1269-1274
104. Qiu C, Cotch MF, Sigurdsson S, Jonsson PV, Jonsdottir MK, Sveinbjrnsdottir S, et al. Cerebral microbleeds, retinopathy, and dementia: the AGES-Reykjavik Study. Neurology 2010; 75: 2221-2228
105. van Es AC, van der Grond J, de Craen AJ, Westendorp RG, Bollen EL, Blauw GJ, et al. Cerebral microbleeds and cognitive functioning in the PROSPER study. Neurology 2011; 77: 1446-1452
106. Yakushiji Y, Noguchi T, Hara M, Nishihara M, Eriguchi M, Nanri Y, et al. Distributional impact of brain microbleeds on global cognitive function in adults without neurological disorder. Stroke 2012; 43: 1800-1805
107. Brundel M, Reijmer YD, van Veluw SJ, Kuijf HJ, Luijten PR, Kappelle LJ, et al. Cerebral microvascular lesions on high-resolution 7-Tesla MRI in patients with type 2 diabetes. Diabetes 2014; 63: 3523-3529
108. van der Vlies AE, Goos JD, Barkhof F, Scheltens P and van der Flier WM. Microbleeds do not affect rate of cognitive decline in Alzheimer disease. Neurology 2012; 79: 763-769
109. Haller S, Bartsch A, Nguyen D, Rodriguez C, Emch J, Gold G, et al. Cerebral microhemorrhage and iron deposition in mild cognitive impairment: susceptibilityweighted MR imaging assessment. Radiology 2010; 257: 764-773
110. Goos JD, Kester MI, Barkhof F, Klein M, Blankenstein MA, Scheltens P, et al. Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition. Stroke 2009; 40: 3455-3460
111. Poels MM, Ikram MA, van der Lugt A, Hofman A, Niessen WJ, Krestin GP, et al. Cerebral microbleeds are associated with worse cognitive function: the Rotterdam Scan Study. Neurology 2012; 78: 326-333
112. Patel B, Lawrence AJ, Chung AW, Rich P, Mackinnon AD, Morris RG, et al. Cerebral microbleeds and cognition in patients with symptomatic small vessel disease. Stroke 2013; 44: 356-361
113. Werring DJ, Frazer DW, Coward LJ, Losseff NA, Watt H, Cipolotti L, et al. Cognitive dysfunction in patients with cerebral microbleeds on T2-weighted gradientecho MRI. Brain 2004; 127: 2265-2275
114. van Norden AG, van den Berg HA, de Laat KF, Gons RA, van Dijk EJ and de Leeuw FE. Frontal and temporal microbleeds are related to cognitive function: the Radboud University Nijmegen Diffusion Tensor and Magnetic Resonance Cohort (RUN DMC) Study. Stroke 2011; 42: 3382-3386
115. Maillard P, Carmichael O, Fletcher E, Reed B, Mungas D and DeCarli C. Coevolution of white matter hyperintensities and cognition in the elderly. Neurology 2012; 79: 442-448
116. Prins ND, van Dijk EJ, den HT, Vermeer SE, Jolles J, Koudstaal PJ, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005; 128: 2034-2041
117. Inzitari D, Pracucci G, Poggesi A, Carlucci G, Barkhof F, Chabriat H, et al. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ 2009; 339: b2477
118. Smith EE, Gurol ME, Eng JA, Engel CR, Nguyen TN, Rosand J, et al. White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage. Neurology 2004; 63: 1606-1612
119. Arvanitakis Z, Leurgans SE, Barnes LL, Bennett DA and Schneider JA. Microinfarct pathology, dementia, and cognitive systems. Stroke 2011; 42: 722-727
120. Troncoso JC, Zonderman AB, Resnick SM, Crain B, Pletnikova O and O'Brien RJ. Effect of infarcts on dementia in the Baltimore longitudinal study of aging. Ann Neurol 2008; 64: 168-176
121. Kovari E, Gold G, Herrmann FR, Canuto A, Hof PR, Michel JP, et al. Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke 2004; 35: 410-414
122. van Rooden S, Goos JD, van Opstal AM, Versluis MJ, Webb AG, Blauw GJ, et al. Increased number of microinfarcts in Alzheimer disease at 7-T MR imaging. Radiology 2014; 270: 205-211
123. van Veluw SJ, Hilal S, Kuijf HJ, Ikram MK, Xin X, Tan BY, et al. Cortical microinfarcts on 3T MRI: clinical correlates in memory-clinic patients. Alzheimers Dement2015; (in press)
124. Vernooij MW, Ikram MA, Vrooman HA, Wielopolski PA, Krestin GP, Hofman A, et al. White matter microstructural integrity and cognitive function in a general elderly population. Arch Gen Psychiatry 2009; 66: 545-553
125. O'Sullivan M, Barrick TR, Morris RG, Clark CA and Markus HS. Damage within a network of white matter regions underlies executive dysfunction in CADASIL. Neurology 2005; 65: 1584-1590
126. Reijmer YD, Leemans A, Brundel M, Kappelle LJ and Biessels GJ, Utrecht Vascular Cognitive Impairment (VCI) Study Group. Disruption of the cerebral white matter network is related to slowing of information processing speed in patients with type 2 diabetes. Diabetes 2013; 62: 2112-2115
127. Viswanathan A, Patel P, Rahman R, Nandigam RN, Kinnecom C, Bracoud L, et al. Tissue microstructural changes are independently associated with cognitive impairment in cerebral amyloid angiopathy. Stroke 2008; 39: 1988-1992
128. Hagmann P, Cammoun L, Gigandet X, Meuli R, Honey CJ, Van Wedeen J, et al. Mapping the structural core of human cerebral cortex. PLoS Biol 2008; 6: 1479-1493
129. Smith EE, O'Donnell M, Dagenais G, Lear SA, Wielgosz A, Sharma M, et al. Early cerebral small vessel disease and brain volume, cognition, and gait. Ann Neurol 2014; 77: 251-261
130. Lawrence AJ, Chung AW, Morris RG, Markus HS and Barrick TR. Structural network efficiency is associated with cognitive impairment in small-vessel disease. Neurology 2014; 83: 304-311
131. Black S, Roman GC, Geldmacher DS, Salloway S, Hecker J, Burns A, et al. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke 2003; 34: 2323-2330
132. Wilkinson D, Doody R, Helme R, Taubman K, Mintzer J, Kertesz A, et al. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology 2003; 61: 479-486
133. Roman GC, Wilkinson DG, Doody RS, Black SE, Salloway SP and Schindler RJ. Donepezil in vascular dementia: combined analysis of two large-scale clinical trials. Dement Geriatr Cogn Disord 2005; 20: 338-344
134. Roman GC, Salloway S, Black SE, Royall DR, Decarli C, Weiner MW, et al. Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size. Stroke 2010; 41: 1213-1221
135. Auchus AP, Brashear HR, Salloway S, Korczyn AD, De Deyn PP, Gassmann-Mayer C, et al. Galantamine treatment of vascular dementia: a randomized trial. Neurology 2007; 69: 448-458
136. Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S and Damaraju CV. Efficacy of galantamine in probable vascular dementia and Zleheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet 2002; 359: 1283-1290
137. Ballard C, Sauter M, Scheltens P, He Y, Barkhof F, van Straaten EC, et al. Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study. Curr Med Res Opin 2008; 24: 2561-2574
138. Orgogozo JM, Rigaud AS, Stoffler A, Mobius HJ and Forette F. Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). Stroke 2002; 33: 1834-1839
139. Wilcock G, Mobius HJ and Stoffler A. A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). Int Clin Psychopharmacol 2002; 17: 297-305
140. Narasimhalu K, Effendy S, Sim CH, Lee JM, Chen I, Hia SB, et al. A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease. Acta Neurol Scand 2010; 121: 217-224
141. Eng JA, Frosch MP, Choi K, Rebeck GW and Greenberg SM. Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 2004; 55: 250-256
142. Kinnecom C, Lev MH, Wendell L, Smith EE, Rosand J, Frosch MP, et al. Course of cerebral amyloid angiopathy-related inflammation. Neurology 2007; 68: 1411-1416
143. Piazza F, Greenberg SM, Savoiardo M, Gardinetti M, Chiapparini L, Raicher I, et al. Anti-amyloid beta autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies. Ann Neurol 2013; 73: 449-458
144. Kloppenborg RP, Richard E, Sprengers ME, Troost D, Eikelenboom P and Nederkoorn PJ. Steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment. J Neuroinflammation 2010; 7: 18-2094-7-18
145. Brundel M, Kwa VI, Bouvy WH, Algra A, Kappelle LJ, Biessels GJ, et al. Cerebral microbleeds are not associated with long-term cognitive outcome in patients with transient ischemic attack or minor stroke. Cerebrovasc Dis 2014; 37: 195-202
146. Biessels GJ and Reijmer YD. Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI? Diabetes 2014; 63: 2244-2252
147. Huijts M, Duits A, van Oostenbrugge RJ, Kroon AA, de Leeuw PW and Staals J. Accumulation of MRI Markers of Cerebral Small Vessel Disease is Associated with Decreased Cognitive Function. A Study in First-Ever Lacunar Stroke and Hypertensive Patients. Front Aging Neurosci 2013; 5: 72
148. Viswanathan A, Godin O, Jouvent E, O'Sullivan M, Gschwendtner A, Peters N, et al. Impact of MRI markers in subcortical vascular dementia: a multi-modal analysis in CADASIL. Neurobiol Aging 2010; 31: 1629-1636
149. Duering M, Righart R, Csanadi E, Jouvent E, Herve D, Chabriat H, et al. Incident subcortical infarcts induce focal thinning in connected cortical regions. Neurology 2012; 79: 2025-2028
150. Kidwell CS and Greenberg SM. Red meets white: do microbleeds link hemorrhagic and ischemic cerebrovascular disease? Neurology 2009; 73: 1614-1615
151. Fisher M. Cerebral microbleeds: where are we now. Neurology 2014; 83: 1304-1305
152. Garg RK, Liebling SM, Maas MB, Nemeth AJ, Russell EJ and Naidech AM. Blood pressure reduction, decreased diffusion on MRI, and outcomes after intracerebral hemorrhage. Stroke 2012; 43: 67-71
153. Lee EJ, Hung YC and Lee MY. Early alterations in cerebral hemodynamics, brain metabolism, and bloodbrain barrier permeability in experimental intracerebral hemorrhage. J Neurosurg 1999; 91: 1013-1019
154. Dziedzic T, Bartus S, Klimkowicz A, Motyl M, Slowik A and Szczudlik A. Intracerebral hemorrhage triggers interleukin-6 and interleukin-10 release in blood. Stroke 2002; 33: 2334-2335
155. Jeon SB, Kwon SU, Cho AH, Yun SC, Kim JS and Kang DW. Rapid appearance of new cerebral microbleeds after acute ischemic stroke. Neurology 2009; 73: 1638-1644
156. Akoudad S, Ikram MA, Koudstaal PJ, Hofman A, Niessen WJ, Greenberg SM, et al. Cerebral microbleeds are associated with the progression of ischemic vascular lesions. Cerebrovasc Dis 2014; 37: 382-388
157. Viswanathan A, Rocca WA and Tzourio C. Vascular risk factors and dementia: how to move forward? Neurology 2009; 72: 368-374
158. Vrenken H, Pouwels PJ, Geurts JJ, Knol DL, Polman CH, Barkhof F, et al. Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration. J Magn Reson Imaging 2006; 23: 628-636
159. Ward AM, Mormino EC, Huijbers W, Schultz AP, Hedden T and Sperling RA. Relationships between default-mode network connectivity, medial temporal lobe structure, and age-related memory deficits. Neurobiol Aging 2014; 36: 265-272
160. Veldsman M, Cumming T and Brodtmann A. Beyond BOLD: optimizing functional imaging in stroke populations. Hum Brain Mapp 2015; 36: 1620-1636.